🇺🇸 FDA
Patent

US 9833410

Lyophilized formulation comprising GM-CSF neutralizing compound

granted A61KA61K39/395A61K39/39591

Quick answer

US patent 9833410 (Lyophilized formulation comprising GM-CSF neutralizing compound) held by TAKEDA GMBH expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K39/395, A61K39/39591, A61K47/183, A61K47/22